P.B. No. 173, Chattar Manzil Lucknow – 226 001
Admission to Ph.D. Programme 2012
Online Application Form
For M.Sc candidates
For GPAT candidates
CDRI is a pioneer research organization in the field of biomedical research in India. It has the infrastructure and expertise to develop a drug right from the concept stage to the market. The institute’s latest techniques and services are employed for developing drugs, diagnostics and vaccines to combat diseases prevalent among mankind in general and Indian population in particular. Since its establishment, on 17th Feb. 1951, the institute has provided leadership on all fronts of drug R&D, namely, development of new molecules, novel products, cost-effective indigenous process know how for institute’s candidate drugs and generic drugs/drug intermediates, quality research manpower and trainings in use of sophisticated tools and techniques in drug research. Several of the institute products and process know how have been successfully commercialized leading to treatment of diseases, products availability for indigenous and international markets and generation of foreign exchange. Besides, the Institute has played a critical role in putting the country on the international scene in drug R&D.
CDRI trains a large number of students and has a robust Ph.D. program in different areas of Life sciences/Biotechnology/Chemical/Pharmaceutical sciences, directed towards new drug development. CDRI provides a vibrant academic atmosphere enabling inter-disciplinary and cross-disciplinary areas of research to flourish. The R & D divisions of CDRI where students can pursue their Ph. D. studies are as follows :
• Biochemistry
• Botany
• Clinical & Experimental Medicine
• Drug Target Discovery & Development
• Endocrinology
• Fermentation Technology
• Medicinal & Process Chemistry Division
• Microbiology
• Molecular & Structural Biology
• Parasitology
• Pharmaceutics
• Pharmacokinetics & Metabolism
• Pharmacology
• Toxicology
Thrust areas of research and their objectives are :
Malaria and other Parasitic Diseases
• Development of new drugs/drug combinations as therapeutic interventions for malaria, leishmaniasis and filariasis
• Establish novel target based drug assay protocols for identification of new leads;
• Knowledge generation on parasite biology and host parasite interactions.
Reproductive Health Research, Diabetes & Energy Metabolism
• Development of novel agents for fertility regulation, management of post-menopausal osteoporosis, type II diabetes mellitus, hyperlipidemic condition and other endocrine disorders through modern drug design, scientific validation of traditional remedies;
• Understanding pharmacological basis of actions of promising agents & existing therapeutics and undertake basic research to generate new knowledge on reproductive endocrinology relevant to fertility regulation, osteoporosis and diabetes.
Tuberculosis and Microbial Infections
• Simplification and shortening of treatment for drug-sensitive tuberculosis and search of new treatments for MDR-TB;
• Development of new drugs for bacterial, fungal and viral (HIV and JEV) infections and tuberculosis.
CVS, CNS and Related Disorders
• Development of new target based drugs to alleviate CVS, CNS and related disorders (hypertension, dyslipidemia, atherosclerosis, thrombosis, myocardial infarction, anxiety, psychosis, dementia, stroke, stress, gastric ulcers and inflammation);
• Carry out excellent basic research to delineate the molecular mechanisms of these pathologies so as to identify suitable targets for drug discovery, as well as to analyze the possible mechanism(s) of action of the candidate drugs.
Cancer and Related Areas
• Creation of appropriate platform for interdisciplinary collaborative research;
• Creation of knowledge base in cancer biology;
• Lead identification/optimization to obtain drug-like molecules.
Safety & Clinical Development
• Pre-clinical, clinical development and commercialization of new generation affordable drugs for diseases of national importance and international relevance;
• Center of excellence in the field of Clinical trials, Regulatory toxicology, Safety pharmacology, Pharmaceutics and Pharmacokinetics & metabolism and catering to the needs of pharmaceutical industries.
Excellent synthetic organic chemistry/medicinal chemistry group contributes to all the above research areas in CDRI
Over the last six decades, CDRI has built a unique model for drug research in India – having everything under one roof, from synthesis, screening, development studies, process up-scaling to clinical studies. Keeping in view of the paradigm shift in drug R&D approaches in the last decade, the institute has upgraded its capabilities and strengths to match global standards. The major R&D facilities available at CDRI include overall S&T base for drug discovery & development; Molecular & structural biology equipped with modern facilities for characterization of drug targets and elucidation of mechanism of action; High-throughput screening; Drug quality control, standardization and formulation development; Chemical and fermentation technology development; Sophisticated Analytical Instrument Facility equipped with state of the art analytical equipments; National centre for pharmacokinetic and metabolic studies; National facility for regulatory pharmacology & toxicology; and Knowledge resource centre for the scientists and entrepreneurs involved in biomedical research and pharmaceutical industry.
CDRI research programs envisage to rapidly adopt new approaches and technologies in order to build up its capabilities in drug discovery, research and development. The overall scenario is very promising as the institute have all the expertise, state of the art facilities, ready for shift newly constructed state-of-the-art institute, more than 150 scientists from a wide range of disciplines, 360 technical staff, more than 450 research scholars, the institute is poised to deliver new drugs and technologies in the pursuit of affordable drugs and healthcare for all. Students will have ample opportunities to interact with reputed scientists of the Institute, other CSIR Laboratories and fraternity from Lucknow, national and international laboratories. Students are permitted to attend the conferences at national and international platforms.
The PhD program at CDRI consists of flexible course work, followed by advanced research leading to a PhD thesis on a specific topic. The PhD program is normally completed in 4-5 years.
Admission to the PhD program
Eligibility
M.Sc. or equivalent degree in Life sciences/Biotechnology/Chemical/pharmaceutical sciences and qualified in CSIR-UGC-NET, ICMR, DBT examination for Junior Research Fellowship. The fellowship should be valid as on the date of joining for the session commencing January 2012.
GPAT qualified second year, 3rd Semester students pursuing M.S. (Pharm) or M. Pharm. in Pharmaceutical/Pharmacology disciplines only may apply for GATE-JRF positions tenable at CDRI from July 2012.
How to apply ?
Advertisement of Admission process and schedule of application subission etc. are advertised on our website twice a year.
(Click for current Advertisement)
After the advertisement is uploaded, the desirous candidates need to fill up the on-line application form that is available at the institute’s website.
After submitting the online application form, applicants need to get a print out of the system generated page containing the ID ticket.
Applicants are required to send the ID ticket along with their photograph, photocopies of certificates of date of birth, educational qualifications and proof for qualifying JRF/GPAT by post to Scientist-in-Charge, Academic Affairs Division, Central Drug Research Institute (CSIR), Chattar Manzil, Lucknow-226 001
The last date of receipt of documents is as per the schedule advertised. ( Last date of current Admission process is 12th October, 2011)
Applications without hard copy submission of documents are not considered.
Selection Procedure
All the applications are screened by a committee.
Candidates who are found suitable are called for interview/counselling at CDRI, Lucknow to be held on scheduled dates which are duly intimated to the selected applicants.
The committee sets up criteria for short listing the candidates.
No TA is paid by CDRI
Candidates have to make their own arrangements for 2-3 days stay at Lucknow.
The number of students to be selected will depend on the vacancies available with scientists at CDRI.
Seat Availability
Number of seats available with each Scientist. ( Hyperlink to the list available currently).
Emoluments
Emoluments and other benefits are advertised in the advertisement put up by CSIR for the CSIR NET Examination
Accommodation
A limited Number of accommodation ( Both for boys and girls) is available in the guest house of C D R I situated at the CSIR Apartments, Scetor K, Aliganj, Lucknow
The Moti Mahal Trust situated at a walking distance from the C D R I Campus also provides hostel facilities to C D R I Research students.
General Conditions
The above fellowships are purely temporary and selected candidates will have no claim explicitly or implicitly for any post/position in any of the CSIR Laboratories/Institutes including CDRI. In general, CSIR rules/regulations for selected candidates will be followed to the extent they are applicable.
For clarification please contact:
Scientist-in-Charge
Academic Affairs Division
email : academic_unit@cdri.res.in
0 Comments